Aditxt shareholders approve name change to bitXbio, Inc. and reverse stock split authorization

Aditxt, Inc.

Shareholders approved name change to bitXbio, Inc. (455,456 for, 40,462 against).
Authorized reverse stock split ratio between 1:5 and 1:250, board discretion within one year.
Approved increase of 2021 Omnibus Plan shares from 3 to 350,000 (147,125 for).
Approved 2025 Employee Stock Purchase Plan (158,645 for).
Approved issuance of shares underlying Series A-1, Series C-1, and July warrants for Nasdaq compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.